Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
Abroad (travel likely)RecruitingPHASE1
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Glioblastoma, IDH-wildtype · Glioblastoma · Glioblastoma Multiforme · Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype · GBM · Astrocytoma · Astrocytoma, IDH-Mutant
Locations
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Henry Ford Hospital, Detroit, Michigan, United States
- Columbia University Medical Center - Herbert Irving Pavilion, New York, New York, United States
- Duke University, Durham, North Carolina, United States
- The Cleveland Clinic, Cleveland, Ohio, United States
- Brown University Health/Rhode Island Hospital, Providence, Rhode Island, United States
- UT MD Anderson Cancer Center, Houston, Texas, United States
- University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, United States